Carl Zeiss has ended the first six months of fiscal year 2010/11 with a substantial improvement in sales and earnings over the previous year: revenues totaled EUR 2.143 billion, and earnings before income tax (EBIT) EUR 355 million. In addition to the full consolidation of the eyeglass business as the new Vision Care business group for the first time, strong organic growth – particularly in the Semiconductor Manufacturing Technology, Medical Systems and Industrial Metrology business groups – contributed to the positive half-yearly balance sheet presented by the company in Stuttgart.
You can find the complete text at:
http://www.zeiss.de/C1256A770030BCE0/WebViewAllE/B7427622658010BDC125788E001F53E0
